Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

Eriko Tokunaga(Kyushu University), Yoshihiko Maehara(Kyushu University)
International Journal of Cancer
July 27, 2005
Cited by 176


Related Papers